Icagen Reports First Quarter 2006 Financial Results | Nachrichten |

Icagen Reports First Quarter 2006 Financial Results: "The Company's collaboration with Astellas Pharma, Inc. ('Astellas'), the research phase of which was completed during 2003, allows for the selection of compounds generated by the collaboration by Astellas for certain specified indications and by Icagen for certain other specified indications. Astellas is evaluating compounds generated by the collaboration for potential further development in dementia, including Alzheimer's disease."